Call for Abstract
World Haematology and Medical Oncology Conference, will be organized around the theme “An Eye towards “HAEMTOLOGY & MEDICAL ONCOLOGY””
Medical Oncology-2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Medical Oncology-2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Erythrocytes are also called as red platelets which convey oxygen to the body and gather carbon dioxide from the body by the use of haemoglobin and its life expectancy of 120 days. At the edge the leucocytes helps in ensuring the healthy cells in light of the fact that the W.B.C (leucocytes) go about as the defending cells in protecting the immune system from the outside cells. Formation of blood cellular components are called as Haematopoiesis and all the cellular blood segments are gotten from haematopoiesis stem cells in a healthy individual almost 1011–1012 fresh blood cells are produced these assistance in steady peripheral circulation. In the event that there is increments of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.
- Track 1-1Blood components
- Track 1-2Erythrocytes and Leukocytes
- Track 1-3Platelets and Thrombocytopenia
- Track 1-4Hemoglobin and Blood Plasma
- Track 1-5Complete Blood Count and Polycythemia
- Track 1-6Polymorphism and Haematopoiesis
Hematologic Oncology is the branch of medicine study about the diagnosis, prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, haemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Haematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumour. There are different disorders that people are influenced by Hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, haemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, Leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.
- Track 2-1 Myeloma
- Track 2-2Myelodysplastic Syndromes
- Track 2-3 Multiple Myeloma
- Track 2-4Leukaemias
- Track 2-5Lymphoma
- Track 2-6Targeted Therapy
Iron deficiency is the most well-known sort of blood issue we treat. Patients with anaemia have an insufficiency of oxygen-rich red platelets or their red platelets don't work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Anaemia can be constant, or a brief condition caused by other medical problems, including growth treatment, hepatitis C, and HIV/AIDS. Anemia every now and again stays undiscovered in light of the fact that it is a fundamental state of other medical problems, including growth, cardiovascular malady, diabetes, HIV/AIDS, fiery entrail sickness, unending kidney infection, and rheumatoid joint pain. Hemophilia is a rare typicall inherited blood disorder, commonly acquired blood issue in which the blood does not appropriately clump and causeintemprate dying, which can make harm organs, joints, and tissues. Patient may experience the ill effects of the site of damage or from inward dying. Coagulating Disorders Hematologists likewise treat conditions identified with the proteins that trigger draining and thickening, including thrombosis (thickening) and hemostasis (dying). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.
- Track 3-1Hemophilia A, B and C
- Track 3-2 Idiopathic Thrombocytopenic Purpura (ITP)
- Track 3-3Von Willebrand
- Track 3-4Bleeding Disorders & Platelet Function Defects
- Track 3-5 Disease Associated with Coagulation Factors
- Track 3-6Hemoglobinopathies
- Track 3-7Biomarkers for Blood Cancers
Cancer immunology is a branch of immunology that studies interaction between the immune system and cancer cells (likewise called tumours or malignancies). It is a developing field of research that plans to find innovative malignancy immunotherapies to treat and retard movement of disease. The immune system reaction, including the acknowledgment of disease particular antigens, is specifically compelling in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests.
- Track 4-1Immunotherapeutic Approaches
- Track 4-2Hematopoietic System
- Track 4-3Lymphotoxin
- Track 4-4 Immune Tolerance and Deficiencies
- Track 4-5 Immunotherapy
Blood group are of ABO sort and however at introduce the Rh blood gathering of 50 very much characterized antigens in which 5 are more vital they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in anticipation of erythroblast fetalis lacking of Rh antigen it characterized as negative and existences of Rh antigen in blood prompts positive these prompts rh inconsistency. The prevention treatment of illnesses identified with the blood is called as the Hematology. The haematologists conduct a work at cancer to. The disorder of immune system leading to the hypersensitivity is called as Clinical Immunology and the abnormal development of a disease are known as Inflammation and the emerge of an abnormal immune reaction to the body or an immune suppression are known as Auto immune disorder. The undifferentiated cell treatment is utilized to treat or keep an illness or a condition for the mostly Bone marrow undifferentiated cell treatment is seen and as of late umbilical cord treatment Stem cell transplantation methodologies remains an unsafe system with many possible confusions; it is saved for patients with life-threatening sicknesses.
- Track 5-1 Blood Groups and Rh Incompatibility
- Track 5-2 Hematology and Clinical Immunology
- Track 5-3 Immunology of Blood Cancer
- Track 5-4 Inflammatory/Autoimmune Diseases
- Track 5-5Bone Marrow Stem Cell Therapy
- Track 5-6Stem Cell Transplantation Strategies
Ayurvedic drug is an old Indian system of medication which started around 5,000 years prior. It is not only one treatment. It is a method for diagnosing disease and utilizing an extensive variety of medications and strategies. Home grown medication utilizes plants, or blends of plant mixture, to treat disease and promote health. It intends to restore your body's capacity to secure, manage and heal itself. It is an entire body approach, so look at your physical, mental and emotional well-being. It is now and again called phytomedicine, phytotherapy or natural pharmaceutical. Naturopathic specialists (NDs) trust that cancer emerges from an imbalance that causes a systemic breakdown inside the body. Homeopathy depends on the hypothesis of treating like with like. So to treat a sickness a homeopathic specialist (homeopath) utilizes minor dose of a substance that in large dosages would actually cause the symptom of the illness.
- Track 6-1 Ayurvedic Treatment for Cancer
- Track 6-2 Naturpathy and Cancer
- Track 6-3 Cancer and Herbal Medicine
- Track 6-4Homeopathy and Cancer
Hematologic malignancies are types of cancer that starts in the cells of blood-shaping tissue, for example, the bone marrow, or in the cells of the immune system. Cases of hematologic disease are intense and endless Leukemia, lymphomas, and numerous myeloma and myelodysplastic disorders. Myeloproliferative neoplasms, or MPNs, are hematologic growths that arise from dangerous hematopoietic myeloid progenitor cells in the bone marrow, for example, the precursor cells of red cells, platelets and granulocytes .Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera and myelofibrosis . This logical session will concentrate on a wide range of normal or uncommon blood tumours, for example, intense promyelocytic Leukemia (APL) and interminable myelomonocytic Leukemia bristly cell Leukemia (HCL), expansive granular lymphocytic Leukemia (LGL), white blood cell intense lymphoblastic Leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative disease. The estimate of how the disease will go for a patient is called prognosis. There are many factors influence prognosis that include: the kind of cancer and where it is in the body, the phase of the cancer, the cancer grade. Grad gives signs about how rapidly the disease is probably going to develop and spread certain traits of the tumour cells, the age and how healthy body was before cancer and how fruitful is the treatment.
- Track 7-1Hairy Cell Leukaemia (HCL)
- Track 7-2 T-cell Acute Lymphoblastic Leukemia (T-ALL)
- Track 7-3Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma
- Track 7-4Multiple Myeloma
- Track 7-5 Myeloma Prognosis
Protein Biomarkers can be used as biomarkers for early recognition of cancer particularly used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will experience an underlying CT scan to decide if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-respectable stage III and IV disease and a biopsy will be attempted to confirm pancreatic tumour by H&E pathological assay. The presence of cancerous cells by means of pathology is very challenging because of high quantities of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will just initiate on definitive diagnosis of pancreatic cancer. These will see particularly stains neoplastic pancreatic cells would empower the pathologist to confidently diagnose pancreatic cancer and in this way offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been recognized as a highly sensitive (98%) and particular (95%) IHC marker for pancreatic cancer and CRT is looking for a partner to build up an IHC based test to distinguish BI-010 in fine needle suction biopsies from biopsy tests.
- Track 8-1Biomarkers in Cancer Research
- Track 8-2Biomarkers in Medicine
- Track 8-3 Risk Assessment and Diagnosis
- Track 8-4Prognosis and Treatment Predictions
- Track 8-5Molecular Cancer Biomarkers
Bone Marrow Transplantation: A bone marrow transplant, also called as haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow cells. Bone marrow is an elastic tissue found in the empty focuses of a few bones. It contains specialist stem cell, which create the body's cell. A biopsy is a specimen of tissue taken from the body in order to examine it more intently. A doctor should prescribe a biopsy when an initial test suggests that a region of tissue in the body isn't normal. Doctors may call that region of abnormal tissue an injury, a tumour, or a mass.Topics of exchange in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations. An expanding number of diseases may be treated effectively by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell arrangement or product is replaced, it has now turned out to be standard treatment for some types of Leukemia where the transplant gives the protection after deadly marrow removal. As of recent, disease, for example, thalassemia and other acquired metabolic illnesses have also been treated with by BMT. In the past the issues of BMT were for the most part worried about graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was generally fatal. Since the advancement of methods for T cell removal the occurrence of GVHD has greatly diminished. White blood cell removal has likewise permitted HLA haploidentical mismatched graft to be performed effectively for immunodeficiency, but still there is a high graft rejection rate in Leukemia.
- Track 9-1Bone Marrow Surgery
- Track 9-2 Stem Cell Transplantation Surgery
- Track 9-3Hematopoietic Cell Transplantations
- Track 9-4 Development of Investigational New Drug
Oncology is the study of tumour. An oncologist is a master who treats cancer. More often than not, an oncologist manages care and treatment once he or she is determined to have cancer. A therapeutic oncologist treats cancer using chemotherapy or diverse medications, for instance, targeted therapy. A surgical oncologist removes the tumour and nearby tissue in the midst of an operation. A radiation oncologist treats cancer using radiation therapy. Oncologists may segment on the introduction of the kind of treatment given to treat the cancer. Molecular oncology is the study of science of disease and tumour cell at its molecular cell. Surgical oncology is the branch of oncology which deals with the surgery associated with oncology. Gynaecologic oncology is one which focuses on different developments of the female reproductive system
The study of disease transmission of tumour is the investigation of the components affecting development, as a way to deal with finds possible examples and causes. Epidemiology is the investigation of the circulation and determinants of wellbeing related states or events in demonstrated masses, and the use of this audit to control of well-being issues. The most basic risk variable is age. Other hazard components fuse tobacco smoking, alcohol drinking and physical dormancy.
- Track 11-1Tumor Transmission
- Track 11-2Critical Hazards of Cancer
- Track 11-3Environmentally Induced Malignancies
Gynaecologic is a specific field of medication that spotlights on developments of the female conceptive structure, including ovarian cancer, uterine tumour, vaginal disease, cervical cancer, and vulvar disease. As specialists, they have wide get ready in the conclusion and treatment of these tumours. A gynaecologic oncologist is a specialist who represents impressive expert in diagnosing and treating disease that are arranged on a woman's conceptive organs.
- Track 12-1Female Conceptive Organs
- Track 12-2 Ovarian Cancer
- Track 12-3Vulvar Disease
- Track 12-4Gynaecologic Oncologist
- Track 12-5 Cervical Malignancy
An oncology nurse is a selected nurture who takes care of and shows patients who have tumour. Oncology specialists work in a multi-disciplinary gathering, in a combination of settings, from the inpatient ward, where it counts marrow transplant unit, through to the group. They may work with a variety of patients, from children to the elderly, from outpatients through to palliative care.
- Track 13-1Palliative Care
- Track 13-2Marrow Transplant Unit
- Track 13-3 Inpatient and Outpatient Wards